Identifying Circadian Rest-Activity Rhythm Disorders in Patients With Advanced Cancer
Preliminary Validation of a Novel Screening Tool and Diagnostic Criteria to Identify Circadian Rest-Activity Rhythm Disorders in Patients With Advanced Cancer
1 other identifier
observational
100
1 country
2
Brief Summary
Circadian rest-Activity Rhythm disorders (CARDs) are common in patients with cancer, particularly in advanced disease. CARDs are associated with increased symptoms, poorer quality of life, poorer response to anticancer treatments and shorter survival. The goal of this observational study is to see how common CARDs are in patients with advanced cancer and to characterise their rest and activity patterns in more detail. A recent study has outlined a standard way to assess and diagnose a CARD. This study aims to assess patients with advanced cancer for a CARD using a novel screening tool against this newly formed diagnostic criteria. Potentially modifiable risk factors will be considered along with associations between CARDs and symptoms, sleep preferences, sleep quality, daytime sleepiness, quality of life measures and predictors of survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2022
CompletedStudy Start
First participant enrolled
May 15, 2023
CompletedFirst Posted
Study publicly available on registry
September 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2024
CompletedApril 3, 2025
March 1, 2025
1 year
September 9, 2022
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To measure preliminary concurrent validity of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer against diagnostic criteria
Assessing the sensitivity and specificity of the screening tool
Time 1 (baseline), Time 2 (after 72 consecutive hours of accelerometry monitoring)
Secondary Outcomes (18)
To measure test-retest reliability of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer
Time 1 (baseline), Time 2 (after 72 consecutive hours of accelerometry monitoring)
To measure acceptability and ease of use of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer
Time 2 (after 72 consecutive hours of accelerometry monitoring)
To measure acceptability and ease of use of a novel sleep and activity diary in patients with advanced cancer
Time 2 (after 72 consecutive hours of accelerometry monitoring)
To identify the incidence of Circadian rest-activity Rhythm Disorders in patients with advanced cancer
Time 2 (after 72 consecutive hours of accelerometry monitoring)
To assess rest and physical activity patterns in patients with advanced cancer
Time 2 (after 72 consecutive hours of accelerometry monitoring)
- +13 more secondary outcomes
Eligibility Criteria
Patients with locally advanced or metastatic cancer
You may qualify if:
- Adult (18 years of age or older)
- Locally advanced or metastatic cancer
- Outpatient
- Ambulatory
- Prognosis of 3 months or more
You may not qualify if:
- Inpatient
- Shiftworker
- Recent long-haul travel
- Cognitive impairment impacting on ability to complete questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Our Lady's Hospice & Care Services
Dublin, Ireland
St James's Hospital
Dublin, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Palliative Medicine
Study Record Dates
First Submitted
September 9, 2022
First Posted
September 5, 2023
Study Start
May 15, 2023
Primary Completion
May 15, 2024
Study Completion
May 22, 2024
Last Updated
April 3, 2025
Record last verified: 2025-03